Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Regulatory News In Brief

This article was originally published in The Gray Sheet

Executive Summary

Device registration and listing guidance: New 1guidance explains device facility registration and listing procedures established by the FDA Amendments Act of 2007. Since October 2007, domestic device companies and foreign firms that manufacture or process a device sold in the U.S. have had to register and pay an annual facility registration fee for all their establishments, unless a waiver is granted. The Oct. 8 guidance explains the new, online registration and listing process, and the process for requesting a waiver. Registration is complete once the fee is paid, information is submitted online and the company receives notice from FDA. The registration fee for fiscal 2010 is $2,008, rising to $2,179 in FY 2011 and $2,364 in 2012

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT028036

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel